SCHEMBL6147905

SCHEMBL6147905

Cc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(=O)O)C(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MMP9 P14780 9/20 0.62
▸ TDP1 Q9NUW8 1/20 0.61
▸ MMP2 P08253 9/20 0.60
▸ ADAMTS4 O75173 1/20 0.60
▸ ALDH1A1 P00352 1/20 0.58
▸ MAPT P10636 1/20 0.58
▸ POLB P06746 1/20 0.58
▸ CTSL P07711 1/20 0.55
▸ ADAMTS5 Q9UNA0 1/20 0.55
▸ MMP1 P03956 1/20 0.55
▸ MMP3 P08254 1/20 0.55
▸ MMP7 P09237 1/20 0.55
▸ MMP13 P45452 1/20 0.55
▸ MME P08473 1/20 0.52
▸ GAA P10253 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5572742 0.95 MMP9 (0.62) MMP9TDP1MMP2ADAMTS4ALDH1A1
SCHEMBL1203540 0.87 MMP2 (0.79) MMP9TDP1MMP2ADAMTS4ALDH1A1
SCHEMBL697477 0.87 MMP2 (0.79) MMP9TDP1MMP2ADAMTS4ALDH1A1
SCHEMBL697476 0.87 MMP2 (0.79) MMP9TDP1MMP2ADAMTS4ALDH1A1
Hydrochloric Acid SCHEMBL11133046 0.85 MMP2 (0.77) MMP9TDP1MMP2ADAMTS4ALDH1A1
Hydrochloric Acid SCHEMBL3839410 0.85 MMP2 (0.77) MMP9TDP1MMP2ADAMTS4ALDH1A1
SCHEMBL5572780 0.85 MMP9 (0.62) MMP9TDP1MMP2ADAMTS4ALDH1A1
Chloromethane SCHEMBL7649372 0.84 MMP2 (0.75) MMP9TDP1MMP2ADAMTS4ALDH1A1
Hydrochloric Acid SCHEMBL28872216 0.84 MMP2 (0.75) MMP9TDP1MMP2ADAMTS4ALDH1A1
SCHEMBL13957019 0.83 MMP9 (0.66) MMP9TDP1MMP2ADAMTS4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1494700-A2 CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS Cytovia, Inc. (US) 2005-01-12 — — EP disclosed
WO-2004002401-A2 CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS CYTOVIA, INC. (US) 2004-01-08 — — WO disclosed
Send feedback